Clinical Trial Update: Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial is evaluating whether denosumab can prevent breast cancer in women with a BRCA1 germline mutation. The study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: BRCA1 Mutation, Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING